Skip to main content

Taysha Gene Therapies, Inc.

TSHA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001806310

In the last 90 days, Taysha Gene Therapies, Inc. insiders filed 0 open-market purchases and 1 sale; 208 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Taysha Gene Therapies, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
44
−8 vs. Q4 2022
Shares held
16.7M
−2.69M (−13.9%) vs. Q4 2022
Total value
$13.3M
−$30.5M (−69.7%) vs. Q4 2022
New holders
5
12 more added
Sold out
13
14 more reduced

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TSHA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 44 institutions
Q1 2021: 46 institutionsQ2 2021: 49 institutionsQ3 2021: 48 institutionsQ4 2021: 65 institutionsQ1 2022: 71 institutionsQ2 2022: 59 institutionsQ3 2022: 54 institutionsQ4 2022: 52 institutionsQ1 2023: 44 institutionsQ2 2023: 39 institutionsQ3 2023: 63 institutionsQ4 2023: 87 institutionsQ1 2024: 109 institutionsQ2 2024: 107 institutionsQ3 2024: 119 institutionsQ4 2024: 131 institutionsQ1 2025: 127 institutionsQ2 2025: 150 institutionsQ3 2025: 155 institutionsQ4 2025: 195 institutionsQ1 2026: 191 institutionsQ2 2026: 208 institutions
Value heldQ1 2023: $13.3M
Q1 2021: $358.5MQ2 2021: $388.6MQ3 2021: $361.9MQ4 2021: $215.6MQ1 2022: $110.9MQ2 2022: $54.7MQ3 2022: $27.0MQ4 2022: $43.8MQ1 2023: $13.3MQ2 2023: $9.05MQ3 2023: $410.6MQ4 2023: $230.3MQ1 2024: $402.2MQ2 2024: $354.3MQ3 2024: $315.5MQ4 2024: $289.8MQ1 2025: $232.0MQ2 2025: $595.4MQ3 2025: $865.6MQ4 2025: $1.48BQ1 2026: $1.18BQ2 2026: $2.03B
Institutions holding TSHA and their total value by quarter
QuarterHoldersValue
Q2 2026208$2.03B
Q1 2026191$1.18B
Q4 2025195$1.48B
Q3 2025155$865.6M
Q2 2025150$595.4M
Q1 2025127$232.0M
Q4 2024131$289.8M
Q3 2024119$315.5M
Q2 2024107$354.3M
Q1 2024109$402.2M
Q4 202387$230.3M
Q3 202363$410.6M
Q2 202339$9.05M
Q1 202344$13.3M
Q4 202252$43.8M
Q3 202254$27.0M
Q2 202259$54.7M
Q1 202271$110.9M
Q4 202165$215.6M
Q3 202148$361.9M
Q2 202149$388.6M
Q1 202146$358.5M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Taysha Gene Therapies, Inc.; share changes are against Q4 2022.

Institutions holding TSHA in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC3,087,338$2.46M0.00%−117,584−3.7%Reduced
Nantahala Capital Management, LLC1,722,400$1.35M0.13%−1,277,365−42.6%Reduced
Vanguard Group Inc1,583,438$1.26M0.00%+27,772+1.8%Added
Tybourne Capital Management (HK) Ltd1,500,000$1.20M0.12%00.0%Unchanged
Artal Group S.A.1,440,882$1.15M0.07%00.0%Unchanged
Laurion Capital Management LP1,292,600$1.03M0.05%00.0%Unchanged
Franklin Resources Inc810,840$646.7K0.00%−2290.0%Reduced
Sands Capital Ventures, LLC724,873$579.9K0.14%00.0%Unchanged
Alphabet Inc.640,882$512.7K0.03%00.0%Unchanged
Carlson Capital L P504,000$402.0K0.04%−56,000−10.0%Reduced
Millennium Management LLC477,045$380.0K0.00%+90,456+23.4%Added
Acadian Asset Management LLC405,301$321.0K0.00%+143,450+54.8%Added
BlackRock Inc.397,485$317.0K0.00%−316,572−44.3%Reduced
Geode Capital Management, LLC376,464$300.3K0.00%+44,723+13.5%Added
Quantum Private Wealth, LLC359,367$286.6K0.16%+45,910+14.6%Added
Renaissance Technologies LLC249,600$199.0K0.00%−270,200−52.0%Reduced
Bridgeway Capital Management, LLC156,300$124.7K0.00%+51,431+49.0%Added
Bank of America Corp137,001$109.2K0.00%+86,625+172.0%Added
State Street Corp114,920$91.7K0.00%00.0%Unchanged
Susquehanna International Group, LLP100,044$79.8K0.00%−60,680−37.8%Reduced
Morgan Stanley87,813$70.0K0.00%+64,206+272.0%Added
XTX Topco Ltd85,167$67.9K0.01%+85,167New
Northern Trust Corp72,958$58.2K0.00%00.0%Unchanged
Cornercap Investment Counsel Inc55,359$44.2K0.01%00.0%Unchanged
Bank of Montreal49,084$40.2K0.00%−153,115−75.7%Reduced
Virtu Financial LLC45,459$36.0K0.00%+45,459New
Redwood Wealth Management Group, LLC37,750$30.1K0.03%+2,150+6.0%Added
Gsa Capital Partners LLP27,338$22.0K0.00%−156,519−85.1%Reduced
Sargent Investment Group, LLC19,569$15.1K0.00%−23,418−54.5%Reduced
Commonwealth Equity Services, LLC18,725$14.0K0.00%+5,000+36.4%Added
Charles Schwab Investment Management Inc16,140$12.9K0.00%00.0%Unchanged
Kovitz Investment Group Partners, LLC15,000$12.0K0.00%00.0%Unchanged
Engineers Gate Manager LP13,650$10.9K0.00%+13,650New
Citadel Advisors LLC11,293$9.01K0.00%−172,418−93.9%Reduced
Camelot Portfolios, LLC11,000$8.77K0.01%+11,000New
Simplex Trading, LLC10,767$8.00K0.00%+10,767New
Northwestern Mutual Wealth Management Co10,000$7.98K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)7,255$6.00K0.00%−3,763−34.2%Reduced
Wells Fargo & Company4,045$3.23K0.00%+2,777+219.0%Added
Group One Trading, L.P.3,991$3.18K0.00%+3,547+798.9%Added
UBS Group AG3,550$2.83K0.00%−198,284−98.2%Reduced
JPMorgan Chase & Co1,782$1.00K0.00%00.0%Unchanged
Allworth Financial LP1,000$7980.00%00.0%Unchanged
Royal Bank of Canada22$00.00%−2−8.3%Reduced
Altium Capital Management LP0$00.00%−359,051−100.0%Sold out
Marshall Wace, LLP0$00.00%−69,296−100.0%Sold out
Barclays PLC0$00.00%−44,013−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−40,301−100.0%Sold out
Caas Capital Management LP0$00.00%−22,994−100.0%Sold out
Jump Financial, LLC0$00.00%−16,917−100.0%Sold out
Maven Securities LTD0$00.00%−15,000−100.0%Sold out
RBF Capital, LLC0$00.00%−13,800−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−12,127−100.0%Sold out
Bordeaux Wealth Advisors LLC0$00.00%−10,000−100.0%Sold out
Quantbot Technologies LP0$00.00%−9,729−100.0%Sold out
Truvestments Capital LLC0$00.00%−380−100.0%Sold out
Money Concepts Capital Corp0$00.00%−115−100.0%Sold out